Pollen allergen products: current standardisation issues
Scientific relevance. Pollen allergen medicines are in high demand, and their therapeutic benefits directly correlate with their standardisation. Better diagnosis and treatment of allergic diseases require state-of-the-art procedures for assessing the allergenic activity of pollen allergen products...
| Main Authors: | , , , , , |
|---|---|
| Format: | Article |
| Language: | Russian |
| Published: |
Ministry of Health of the Russian Federation. Federal State Budgetary Institution «Scientific Centre for Expert Evaluation of Medicinal Products»
2023-10-01
|
| Series: | Биопрепараты: Профилактика, диагностика, лечение |
| Subjects: | |
| Online Access: | https://www.biopreparations.ru/jour/article/view/527 |
| _version_ | 1826566467421732864 |
|---|---|
| author | E. I. Sakanyan M. A. Yasnaya V. F. Vul R. A. Bubenchikov N. V. Vinokurova E. S. Yurtaeva |
| author_facet | E. I. Sakanyan M. A. Yasnaya V. F. Vul R. A. Bubenchikov N. V. Vinokurova E. S. Yurtaeva |
| author_sort | E. I. Sakanyan |
| collection | DOAJ |
| description | Scientific relevance. Pollen allergen medicines are in high demand, and their therapeutic benefits directly correlate with their standardisation. Better diagnosis and treatment of allergic diseases require state-of-the-art procedures for assessing the allergenic activity of pollen allergen products using reference standards and physicochemical testing methods.Aim. The study aimed at developing methodological approaches to the standardisation of pollen allergen products in order to shift to measuring their potency in allergenic activity units (AAU) and bring their quality in line with the requirements of the State Pharmacopoeia of the Russian Federation.Materials and methods. The study used pollen allergen reference standards by Microgen, the WHO International Standard for timothy grass (Phleum pratense) pollen extract, a gel filtration standard kit of molecular weight markers ranging from 1.35 to 670 kDa, bovine serum albumin, serum samples with specific IgE obtained from donors sensitised to the study pollen allergens, labelled anti-human IgE antibodies, and reference standards for determining residual volatile solvents by gas chromatography. The identification of in-house reference standards for the potency of pollen allergens involved Western blotting (for allergenic components). The total protein content was determined by Bradford’s assay. In addition, the authors used high-performance liquid chromatography to study protein fractions and gas–liquid chromatography to determine the content of residual organic solvents.Results. To substitute the existing method of non-specific characterisation of allergenic activity in protein nitrogen units (PNU), the authors developed and tested a new method to control allergenic activity in allergenic activity units (AAU) based on an in vitro competitive enzyme-linked immunosorbent assay (ELISA) procedure developed and validated in this study. Furthermore, the authors developed and certified 15 primary in-house reference standards with allergenic activity established in AAU/mL using skin tests in vivo. The experimental data were analysed to standardise the allergenic activity of the pollen allergens manufactured by Microgen. The authors developed physicochemical methods for the certification of in-house reference standards and validated these methods in accordance with the State Pharmacopoeia of the Russian Federation. The study involved selecting chromatographic separation conditions for residual organic solvents (acetone and diethyl ether) and establishing system suitability criteria for the chromatographic system. The allergenic activity of secondary in-house reference standards was certified against that of primary in-house reference standards using competitive ELISA. Thus, the authors managed to shift to the standardisation of pollen allergen products in vitro.Conclusions. The authors developed their competitive ELISA-based method to standardise pollen allergen products by comparing the inhibition of immune responses to a product and a standard. The study demonstrated the feasibility of substituting allergenic activity quantification (in AAU) for protein nitrogen content determination (in PNU) and showed the first example of using AAU for the certification of in-house reference standards. Additionally, the authors developed and validated an analytical procedure for determining the content of residual organic solvents in pollen allergen products by gas–liquid chromatography. |
| first_indexed | 2024-03-08T21:43:07Z |
| format | Article |
| id | doaj.art-7cdc3c7a8aae44f9b991d41143dd311a |
| institution | Directory Open Access Journal |
| issn | 2221-996X 2619-1156 |
| language | Russian |
| last_indexed | 2025-03-14T10:52:07Z |
| publishDate | 2023-10-01 |
| publisher | Ministry of Health of the Russian Federation. Federal State Budgetary Institution «Scientific Centre for Expert Evaluation of Medicinal Products» |
| record_format | Article |
| series | Биопрепараты: Профилактика, диагностика, лечение |
| spelling | doaj.art-7cdc3c7a8aae44f9b991d41143dd311a2025-03-02T10:49:22ZrusMinistry of Health of the Russian Federation. Federal State Budgetary Institution «Scientific Centre for Expert Evaluation of Medicinal Products»Биопрепараты: Профилактика, диагностика, лечение2221-996X2619-11562023-10-01233-136737810.30895/2221-996X-2023-23-3-1-367-378341Pollen allergen products: current standardisation issuesE. I. Sakanyan0M. A. Yasnaya1V. F. Vul2R. A. Bubenchikov3N. V. Vinokurova4E. S. Yurtaeva5Microgen Scientific Industrial Company for Immunobiological MedicinesAllergen, Branch of Microgen Scientific Industrial Company for Immunobiological MedicinesAllergen, Branch of Microgen Scientific Industrial Company for Immunobiological MedicinesMicrogen Scientific Industrial Company for Immunobiological MedicinesMicrogen Scientific Industrial Company for Immunobiological MedicinesMicrogen Scientific Industrial Company for Immunobiological MedicinesScientific relevance. Pollen allergen medicines are in high demand, and their therapeutic benefits directly correlate with their standardisation. Better diagnosis and treatment of allergic diseases require state-of-the-art procedures for assessing the allergenic activity of pollen allergen products using reference standards and physicochemical testing methods.Aim. The study aimed at developing methodological approaches to the standardisation of pollen allergen products in order to shift to measuring their potency in allergenic activity units (AAU) and bring their quality in line with the requirements of the State Pharmacopoeia of the Russian Federation.Materials and methods. The study used pollen allergen reference standards by Microgen, the WHO International Standard for timothy grass (Phleum pratense) pollen extract, a gel filtration standard kit of molecular weight markers ranging from 1.35 to 670 kDa, bovine serum albumin, serum samples with specific IgE obtained from donors sensitised to the study pollen allergens, labelled anti-human IgE antibodies, and reference standards for determining residual volatile solvents by gas chromatography. The identification of in-house reference standards for the potency of pollen allergens involved Western blotting (for allergenic components). The total protein content was determined by Bradford’s assay. In addition, the authors used high-performance liquid chromatography to study protein fractions and gas–liquid chromatography to determine the content of residual organic solvents.Results. To substitute the existing method of non-specific characterisation of allergenic activity in protein nitrogen units (PNU), the authors developed and tested a new method to control allergenic activity in allergenic activity units (AAU) based on an in vitro competitive enzyme-linked immunosorbent assay (ELISA) procedure developed and validated in this study. Furthermore, the authors developed and certified 15 primary in-house reference standards with allergenic activity established in AAU/mL using skin tests in vivo. The experimental data were analysed to standardise the allergenic activity of the pollen allergens manufactured by Microgen. The authors developed physicochemical methods for the certification of in-house reference standards and validated these methods in accordance with the State Pharmacopoeia of the Russian Federation. The study involved selecting chromatographic separation conditions for residual organic solvents (acetone and diethyl ether) and establishing system suitability criteria for the chromatographic system. The allergenic activity of secondary in-house reference standards was certified against that of primary in-house reference standards using competitive ELISA. Thus, the authors managed to shift to the standardisation of pollen allergen products in vitro.Conclusions. The authors developed their competitive ELISA-based method to standardise pollen allergen products by comparing the inhibition of immune responses to a product and a standard. The study demonstrated the feasibility of substituting allergenic activity quantification (in AAU) for protein nitrogen content determination (in PNU) and showed the first example of using AAU for the certification of in-house reference standards. Additionally, the authors developed and validated an analytical procedure for determining the content of residual organic solvents in pollen allergen products by gas–liquid chromatography.https://www.biopreparations.ru/jour/article/view/527medicinal products of pollen allergenspotencyallergenic activityresidual organic solventstotal proteincompetitive enzyme-linked immunosorbent assay |
| spellingShingle | E. I. Sakanyan M. A. Yasnaya V. F. Vul R. A. Bubenchikov N. V. Vinokurova E. S. Yurtaeva Pollen allergen products: current standardisation issues Биопрепараты: Профилактика, диагностика, лечение medicinal products of pollen allergens potency allergenic activity residual organic solvents total protein competitive enzyme-linked immunosorbent assay |
| title | Pollen allergen products: current standardisation issues |
| title_full | Pollen allergen products: current standardisation issues |
| title_fullStr | Pollen allergen products: current standardisation issues |
| title_full_unstemmed | Pollen allergen products: current standardisation issues |
| title_short | Pollen allergen products: current standardisation issues |
| title_sort | pollen allergen products current standardisation issues |
| topic | medicinal products of pollen allergens potency allergenic activity residual organic solvents total protein competitive enzyme-linked immunosorbent assay |
| url | https://www.biopreparations.ru/jour/article/view/527 |
| work_keys_str_mv | AT eisakanyan pollenallergenproductscurrentstandardisationissues AT mayasnaya pollenallergenproductscurrentstandardisationissues AT vfvul pollenallergenproductscurrentstandardisationissues AT rabubenchikov pollenallergenproductscurrentstandardisationissues AT nvvinokurova pollenallergenproductscurrentstandardisationissues AT esyurtaeva pollenallergenproductscurrentstandardisationissues |